The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?

Seven guanylate-binding proteins (GBPs, GBP1–7), identified as a subfamily of interferon-γ-induced guanosine triphosphate hydrolases (GTPases), has been reported to be closely associated with tumor progression, metastasis, and prognosis of cancer patients in recent years. However, the expression pat...

Full description

Bibliographic Details
Main Authors:	Zhuang Liu, Jifeng Sun, Ting Gong, Huixin Tang, Yanna Shen, Chang Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Genetics
Subjects:	guanylate-binding proteins lower-grade glioma prognosis immune infiltration pathway analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2021.651348/full

Similar Items

Proposed novel classification of circumscribed Lower-Grade Gliomas (cLGG) vs. infiltrating Lower-Grade Gliomas (iLGG): Correlations of radiological features and clinical outcomes
by: Ahsan Ali Khan, et al.
Published: (2024-07-01)

Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
by: Li Xiao-min, et al.
Published: (2023-10-01)

Classification of diffuse lower‐grade glioma based on immunological profiling
by: Fan Wu, et al.
Published: (2020-09-01)

Expression and clinical significance of RBBP4 gene in lower-grade glioma: An integrative analysis
by: Ruofei Liang, et al.
Published: (2023-09-01)

Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma
by: Jin Zhu, et al.
Published: (2019-09-01)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
by: Xiaoshuai Ji, et al.
Published: (2020-10-01)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas
by: Ming Wang, et al.
Published: (2021-11-01)

Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas
by: Qiankun Ji, et al.
Published: (2022-05-01)

Staged resection of multilobar lower-grade glioma: Case report and review of the literature
by: Ronald Sahyouni, et al.
Published: (2022-06-01)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
by: Shengchao Xu, et al.
Published: (2021-09-01)

Integrative Analysis of a Novel Eleven-Small Nucleolar RNA Prognostic Signature in Patients With Lower Grade Glioma
by: Teng Deng, et al.
Published: (2021-06-01)

Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes
by: Junsheng Li, et al.
Published: (2022-10-01)

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
by: Qiang Zhang, et al.
Published: (2021-07-01)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01)

Identification of Immunological Characteristics and Immune Subtypes Based on Single-Sample Gene Set Enrichment Analysis Algorithm in Lower-Grade Glioma
by: Yunyang Zhu, et al.
Published: (2022-05-01)

Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs
by: Chen S, et al.
Published: (2021-11-01)

Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
by: Junsheng Li, et al.
Published: (2022-04-01)

The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases
by: Yichen Li, et al.
Published: (2022-06-01)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
by: Li Lin, et al.
Published: (2021-10-01)

Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma
by: Shenbin Xu, et al.
Published: (2021-09-01)

Liquid biopsy-based identification of prognostic and immunotherapeutically relevant gene signatures in lower grade glioma
by: Changwu Wu, et al.
Published: (2023-02-01)

Expression and prognosis of GNG5 in lower-grade glioma using public database
by: Xiaohui Tan, et al.
Published: (2022-12-01)

Co‐amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma
by: Haiwei Wang, et al.
Published: (2023-02-01)

A Risk Model Developed Based on Homologous Recombination Deficiency Predicts Overall Survival in Patients With Lower Grade Glioma
by: Hao Peng, et al.
Published: (2022-07-01)

Integrated analysis of necroptosis related gene signature to predict clinical outcomes, immune status and drug sensitivity in lower grade Glioma
by: Xiqi Hu, et al.
Published: (2024-01-01)

N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas
by: Feng Yuan, et al.
Published: (2022-09-01)

CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways
by: Zeyu Wang, et al.
Published: (2022-02-01)

Immune-related genes with APA in microenvironment indicate risk stratification and clinical prognosis in grade II/III gliomas
by: Shengchao Xu, et al.
Published: (2021-03-01)

PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma
by: Wenqian Zhi, et al.
Published: (2023-09-01)

Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
by: Kaijie Chen, et al.
Published: (2022-07-01)

Guanylate‐binding proteins signature predicts favorable prognosis, immune‐hot microenvironment, and immunotherapy response in hepatocellular carcinoma
by: Yumei Ning, et al.
Published: (2023-08-01)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
by: Wen Yin, et al.
Published: (2020-08-01)

Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma
by: Pei-Feng Liu, et al.
Published: (2021-08-01)

ABRACL as a potential prognostic biomarker and correlates with immune infiltration in low-grade gliomas
by: Bohan Liu, et al.
Published: (2022-12-01)

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
by: Qijun Xie, et al.
Published: (2022-06-01)

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
by: Jin-Cheng Guo, et al.
Published: (2021-03-01)

Resilience in Lower Grade Glioma Patients
by: Ellen Fröhlich, et al.
Published: (2022-11-01)

Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer
by: Jing Zhao, et al.
Published: (2020-01-01)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
by: Louise Carstam, et al.
Published: (2022-01-01)

Comparative profiling of immune genes improves the prognoses of lower grade gliomas
by: Zhiliang Wang, et al.
Published: (2022-04-01)